Citizen Science
By Thomas Insel on April 26, 2012
Presentations at a recent meeting in San Diego showed how new technologies are being used to change the culture of science, empowering patients, and fueling innovative research approaches.
More Science News about Clinical Research and Trials
By Thomas Insel on April 26, 2012
Presentations at a recent meeting in San Diego showed how new technologies are being used to change the culture of science, empowering patients, and fueling innovative research approaches.
By Thomas Insel on April 20, 2012
While fewer medical students are choosing psychiatry in the U.K., in the U.S. psychiatry is attracting increasing numbers of elite MD-PhD students who want to do research. These young scientists are committed to developing a new scientific basis for clinical care.
By Thomas Insel on January 05, 2012
Dr. Insel discusses opportunities for treatment development.
By Thomas Insel on December 23, 2011
Dr. Insel shares NIMH’s Top 10 Research Advances for 2011.
By Thomas Insel on December 22, 2011
Dr. Insel discusses opportunities for treatment development.
More Posts about Clinical Research and Trials
More Meeting Summaries about Clinical Research and Trials
September 03, 2007
A recently published research paper (September 2007, Archives of General Psychiatry) reported a 40-fold increase in the rate of diagnosing bipolar disorder in youth over the past decade.
December 01, 2006
The recent publication (December 1, 2006, American Journal of Psychiatry) of the cost-effectiveness results from the National Institute of Mental Health (NIMH)-funded Clinical Antipsychotic Trials in Intervention Effectiveness (CATIE) has raised questions among advocates, families, and clinicians about reimbursement policies for antipsychotic medications.
October 12, 2006
The recent publication of phase 1 results from the NIMH-funded Clinical Antipsychotic Trials in Intervention Effectiveness for Alzheimer's disease (CATIE-AD) in the New England Journal of Medicine provides new information about the use of several "atypical" antipsychotic medications for the treatment of psychotic symptoms in patients with Alzheimer's disease.